SPY328.73+5.23 1.62%
DIA271.70+3.60 1.34%
IXIC10,913.56+241.30 2.26%

Raymond James Initiates Coverage On GW Pharmaceuticals with Market Perform Rating

Raymond James analyst Danielle Brill initiates coverage on GW Pharmaceuticals (NASDAQ:GWPH) with a Market Perform rating.

Benzinga · 08/25/2020 10:47
Raymond James analyst Danielle Brill initiates coverage on GW Pharmaceuticals (NASDAQ: GWPH) with a Market Perform rating.